Berkshire Hathaway provides an "anchor" to a portfolio with its massive war chest of cash. Apple's business is seeing accelerating momentum. These two stocks give investors access to both cutting-edge ...
Zach Charbonnet, shown celebrating an earlier touchdown, helped the Seahawks convert a wild 2-point conversion. Soobum Im / Getty Images For as action-packed as the Seattle Seahawks’ rapid comeback ...
We will likely never see a two-point conversion like the one the Seattle Seahawks pulled off ever again. On Thursday, the Seahawks hosted the Los Angeles Rams in a pretty important matchup for playoff ...
In one of the craziest sequences of the season, the Seattle Seahawks got a game-tying two-point conversion against the Los Angeles Rams after a replay review. The officials ruled Sam Darnold threw a ...
Things are getting nuts in Seattle. After the Rams took a 30–14, two-score lead over the Seahawks on Thursday night with less than a quarter to go, Seattle has since come back to tie the game, 30–30, ...
This Seattle Seahawks season keeps getting more and more strange. Remember the George Holani kickoff recovery touchdown earlier in the season? That was possibly the weirdest way an NFL team can score ...
(RTTNews) - Q32 Bio Inc. (QTTB) has sold its Phase 2 complement inhibitor ADX-097 to Akebia Therapeutics, Inc. (AKBA), securing upfront and milestone payments that will extend its cash runway into the ...
Investing.com -- Q32 Bio Inc (NASDAQ:QTTB) stock surged 94% in premarket trading Monday after the clinical-stage biotechnology company announced the sale of its Phase 2 complement inhibitor, ADX-097, ...
(RTTNews) - Biotechnology company Q32 Bio, Inc. (QTTB) announced Monday it has sold its Phase 2 complement inhibitor, ADX-097, to Akebia Therapeutics, Inc. (AKBA). ADX-097, the lead product candidate ...
All products featured here are independently selected by our editors and writers. If you buy something through links on our site, Gizmodo may earn an affiliate commission. Reading time 8 minutes Color ...